Ángel González-Pinto

Ángel González-Pinto

Auto-generated profile, based on publicly available information

Ángel González-Pinto

Department of Cardiac Surgery, Hospital General Universitario Gregorio Marañón, Madrid, Spain

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 May 2025 in JMIR Serious Games
Verified
Journal Article
Open access
ARAlberto Rubio-López
Alberto Rubio-López
Rodrigo García-CarmonaRodrigo García-Carmona
Rodrigo García-Carmona
LRLaura Zarandieta Román
Laura Zarandieta Román
ANAlejandro Rubio Navas
Alejandro Rubio Navas
AGAngel González-Pinto
Angel González-Pinto
PCPablo Cardinal
Pablo Cardinal
Background: Virtual reality (VR) is increasingly used in medical education, providing immersive environments for training in high-risk procedures such as pericardiocentesis. This lifesaving procedure requires technical precision and induces cognitive and physiological stress. Evaluating both usability and stress responses in a VR-based pericardiocentesis simulation is essential. Heart rate variability (HRV) serves as an objective stress marker, while prior VR experience may influence usability and stress perception. Objectives: This study aimed to assess the usability of a VR-based pericardiocentesis simulation, examine the relationship between usability perceptions and physiological stress (HRV), and determine the impact of prior VR experience on usability scores and stress responses. Methods: A total of 119 final-year medical students participated in a VR pericardiocentesis simulation. Usability was evaluated using the System Usability Scale (SUS), the Post-Study System Usability Questionnaire, the Presence Questionnaire, and the Simulator Sickness Questionnaire. Physiological stress was assessed through HRV parameters, including the root-mean-square of successive differences (rMSSDs), percentage of differences greater than 50 ms (PNN50), low-frequency to high-frequency ratio, and nonlinear HRV indices (SD1/SD2 ratio, Poincaré area). Statistical analyses included descriptive statistics, Spearman correlations, and Mann-Whitney U tests to explore relationships between usability, stress, and prior VR experience. Results: The VR simulation received a mean SUS score of 75.00 (SD 6.41; 95% CI 73.42‐76.58), exceeding the general usability threshold of 68 (P=.002). The mean Post-Study System Usability Questionnaire score of 2.92 (SD 1.83; 95% CI 2.55‐3.29) indicated moderate satisfaction, while the mean Presence Questionnaire score of 109.46 (SD 9.12; 95% CI 107.88‐111.04) reflected strong immersion. Simulator sickness symptoms were mild (mean Simulator Sickness Questionnaire score 12.43, SD 15.41; 95% CI 9.28‐15.58), although novice users reported significantly higher nausea levels (P=.02). Physiological stress analysis revealed a mean rMSSD of 281.27 (SD 98.99; 95% CI 259.45‐303.09) ms and PNN50 of 56.85% (SD 19.70%; 95% CI 52.23%‐61.47%), indicating moderate autonomic balance. A significant negative correlation was observed between HRV parameters (rMSSD and PNN50) and simulator sickness (P=.04; Spearman ρ=−0.23), suggesting that higher physiological stress was associated with increased simulator sickness symptoms. Prior VR experience was linked to higher usability scores (SUS +5.2; 95% CI 3.12-7.28; P=.03) and lower simulator sickness symptoms (P=.02) but did not significantly affect HRV markers. Conclusions: VR-based simulations for high-risk medical procedures are effective training tools with high usability (SUS=75) and strong immersion. Simulator sickness correlated with physiological stress, emphasizing the need for design refinements to improve user comfort. Prior VR experience improved usability and reduced simulator sickness but did not significantly impact HRV markers. Future research should refine VR interfaces to balance immersion with minimized cognitive and physical discomfort.

27 May 2025 in Revista Española de Quimioterapia
Verified
Journal Article
Open access
MPMaría Jesús Pérez-Granda
María Jesús Pérez-Granda
EBEmilio Bouza
Emilio Bouza
JBJosé María Barrio-Gutiérrez
José María Barrio-Gutiérrez
MMMarina Machado
Marina Machado
AEAgustín Estevez
Agustín Estevez
CGCardiovascular Infection Study Group
Cardiovascular Infection Study Group
Background: Postsurgical mediastinitis (PSM) is a serious and potentially life-threatening complication of Major Heart Surgery (MHS). Data on the evolution of the incidence of PSM after MHS in large series of operated patients in recent years are scarce. The aim of our study was to evaluate the trend of incidence, microbial etiology, and associated mortality of PSM at a referral MHS unit in the last 12 years. Material and methods: The study was conducted at a tertiary hospital in Madrid, Spain. We carried out a retrospective and cross-sectional study that included all patients who underwent CCM and developed MPQ between January 2012 and December 2023 at our institution. It was conducted at a tertiary hospital in Madrid, Spain. We carried out a retrospective and cross-sectional study that included all patients who underwent CCM and developed MPQ between January 2012 and December 2023 at our institution. Results: During the 12-year study period, a total of 5,584 patients underwent MHS at our institution. The incidence rate of PSM varied yearly between 1.16 and 2.34 episodes/100 surgical procedures. Overall, the 89 patients with PSM were analyzed (92 different episodes). Their median age was 67 years (IQR 56-75) and most of them were male (63%). Their median Euroscore was 7 (IQR 5-9.5). Main type of heart surgery in patients with PSM was: coronary artery bypass graft in 37% and valve replacement in 32.6%. The more frequent causative microorganisms were: Gram-positive bacteria (59.0%), Gram-negative bacteria (32.4%), fungi (7.6%) and others (1%). Overall, 22 patients died (24.7%). Conclusions: The incidence of PSM has remained stable and below 2.5% in the last 12 years in our institution, but it continues to be an entity associated with high morbidity and mortality and long hospital stays.

1 May 2019 in Cirugía Cardiovascular
Verified
Journal Article
Open access
JGJuan-Miguel Gil-Jaurena
Juan-Miguel Gil-Jaurena
RPRamón Pérez-Caballero
Ramón Pérez-Caballero
APAna Pita
Ana Pita
MGMaría-Teresa González-López
María-Teresa González-López
CPCarlos Pardo
Carlos Pardo
ÁGÁngel González-Pinto
Ángel González-Pinto

1 March 2016 in Cirugía Cardiovascular
Verified
Journal Article
Open access
PDPablo Diez-Villanueva
Pablo Diez-Villanueva
ISIago Sousa
Iago Sousa
Manuel Ruiz MuñozManuel Ruiz Muñoz
Manuel Ruiz Muñoz
JHJavier Hortal
Javier Hortal
ÁGÁngel González-Pinto
Ángel González-Pinto
FFFrancisco Fernández-Avilés
Francisco Fernández-Avilés
ResumenLas asistencias ventriculares son dispositivos mecánicos de asistencia circulatoria capaces de generar un flujo sanguíneo que permite apoyar o sustituir la función cardíaca en situaciones de insuficiencia cardiaca terminal y refractaria. El uso de estos dispositivos como puente al trasplante es cada vez mayor en nuestro país. La asistencia ventricular tipo Berlin-Heart EXCOR (Berlin−Heart AG, Berlin, Germany) es un dispositivo de asistencia pulsátil que se utiliza principalmente como puente al trasplante cardiaco cuando se requiere asistencia biventricular en pacientes adultos, en presencia de disfunción ventricular derecha importante. La experiencia con estos pacientes en nuestro país, dada su complejidad y frecuentes complicaciones, ha sido malos hasta la fecha. Presentamos los tres primeros casos de pacientes adultos trasplantados con éxito en España tras el implante de una asistencia biventricular de media duración tipo Berlin−Heart EXCOR. Los tres pacientes eran varones, con edad media de 65 años, y el tiempo medio de asistencia fue de 150 días. El implante de este tipo de asistencia permitió estabilizar la situación hemodinámica del primero de los pacientes (previamente en soporte con ECMO veno-arterial en situación de shock cardiogénico refractario) y normalizar las resistencias vasculares pulmonares de los otros dos (hipertensión pulmonar severa previa al implante que contraindicaba el trasplante cardiaco) permitiendo realizar el trasplante con éxito.AbstractVentricular assist devices provide mechanical circulatory support and are also capable of replacing cardiac function in situations of advanced heart failure. The use of these devices as a bridge to transplantation is growing in our country. Berlin Heart Excor (Berlin Heart AG, Berlin, Germany) is a paracorporeal, pneumatically driven pulsatile flow device, that is mainly used as a bridge to transplantation in adult patients when biventricular support is required, in the presence of significant right ventricular dysfunction. The experience with such patients in our country, given complexity and frequent complications, has been bad so far. We present the first three cases of adult patients successfully transplanted in Spain after Berlin-Heart EXCOR biventricular assist device implantation. All three patients were male, mean age 65 years, and mean time on support was 150 days. This support allowed hemodynamic stabilization in our first patient (previously on venoarterial-ECMO support due to refractory cardiogenic shock) and normalization of pulmonary vascular resistance in the other two (with severe pulmonary hypertension prior to implant) thus contributing to transplantation were carried out with success